APH Form 4: 113,000-Share Option Exercise and Sale at ~$110

Rhea-AI Filing Summary

Amphenol Corp (APH) insider William J. Doherty, President of the CS Division, reported option exercises and immediate sales of Class A common stock. The form shows exercises of stock options with an exercise price of $22.5525 that were converted into 113,000 shares on 08/08/2025 and again on 08/11/2025, with the options listed as exercisable since 05/21/2021 and expiring 05/21/2030.

On each date the acquired shares were sold: the 08/08/2025 sale reported a weighted-average price of $108.8916 (trades ranged $108.7550–$109.1900) and the 08/11/2025 sale reported a weighted-average price of $110.2906 (trades ranged $110.00–$110.9100). After the reported sales the filing shows 0 shares held by the reporting person. The form is signed by a POA, Lance E. D'Amico.

Positive

• Exercise and conversion of vested stock options at an exercise price of $22.5525, demonstrating compensation realization
• Detailed disclosure including weighted-average sale prices and trade ranges supports transparency

Negative

• Insider sales of all acquired shares on 08/08/2025 and 08/11/2025 left the reporting person with 0 shares, representing significant insider selling
• Large share blocks (113,000 shares per transaction) were sold, which may be viewed negatively by some investors depending on context

Insights

Securities Analyst

Officer exercised vested options, sold the resulting shares at about $109–$110, and returned to zero holdings.

The filing documents two paired transactions on 08/08/2025 and 08/11/2025 in which 113,000 option-derived shares were acquired at the option exercise price of $22.5525 and then sold at weighted-average prices of $108.8916 and $110.2906. The stock options were exercisable since 05/21/2021 with expiration 05/21/2030. The filing discloses trade price ranges for the sales and shows the reporting person holding 0 shares after the transactions. These are typical executive option exercises followed by disposition to monetize gains.

Corporate Governance Expert

Transactions appear procedural: option exercises, immediate sales, and a POA-signed filing; disclosure is complete on prices and trade ranges.

The Form 4 includes both the derivative-side detail (exercise price, exercisable and expiration dates) and the non-derivative side (acquisitions and sales with weighted-average sale prices and post-transaction holdings). The signature is provided via a Power of Attorney (Lance E. D'Amico). The explanation lists trade price ranges, which supports transparency about execution. No amendment date or additional restrictions are disclosed in the form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Doherty William J

(Last) (First) (Middle)

C/O AMPHENOL TCS

200 INNOVATIVE WAY, STE 201

(Street)

NASHUA NH 03062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMPHENOL CORP /DE/ [ APH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CS Division

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/08/2025		M		113,000	A	$22.5525	113,000	D
Class A Common Stock	08/08/2025		S		113,000	D	$108.8916(1)(2)	0	D
Class A Common Stock	08/11/2025		M		113,000	A	$22.5525	113,000	D
Class A Common Stock	08/11/2025		S		113,000	D	$110.2906(1)(3)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$22.5525	08/08/2025		M			113,000	05/21/2021	05/21/2030	Class A Common Stock	113,000	$0	113,000	D
Stock Option	$22.5525	08/11/2025		M			113,000	05/21/2021	05/21/2030	Class A Common Stock	113,000	$0	0	D

Explanation of Responses:

1. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. This transaction was executed in multiple trades ranging from $108.7550 to $109.1900.

3. This transaction was executed in multiple trades ranging from $110.00 to $110.9100.

	/s/ Lance E. D'Amico, POA	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did William J. Doherty report on Form 4 for APH?

The filing reports exercise of stock options and subsequent sales of the resulting 113,000 shares on 08/08/2025 and another 113,000 shares on 08/11/2025.

At what price were the APH shares sold?

The weighted-average sale price was $108.8916 for the 08/08/2025 trades (range $108.7550–$109.1900) and $110.2906 for the 08/11/2025 trades (range $110.00–$110.9100).

What was the exercise price of the options exercised by the APH officer?

The reported exercise (conversion) price for the stock options was $22.5525.

How many shares did the reporting person hold after these transactions?

Following the reported sales the Form 4 shows the reporting person beneficially owned 0 shares.

Who signed the Form 4 for the reporting person?

The form is signed by a Power of Attorney, Lance E. D'Amico, with a signature date of 08/12/2025.